Brachytherapy
Volume 7, Issue 1 , Pages 29-36, January 2008

Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: The Allegheny General Hospital experience

  • Mark Trombetta

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212, USA. Tel.: +1-412-359-3400; fax: +1-412-359-3981.
  • ,
  • Thomas Julian

      Affiliations

    • Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA
  • ,
  • Tanuja Bhandari

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
  • ,
  • E. Day Werts

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
  • ,
  • Moyed Miften

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
  • ,
  • David Parda

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA

Received 13 September 2007; received in revised form 27 November 2007; accepted 5 December 2007. published online 18 January 2008.

Abstract 

Purpose

To evaluate lumpectomy followed by interstitial brachytherapy as an acceptable salvage therapy for women who have developed localized recurrence of breast cancer after conservation surgery and postoperative external radiotherapy.

Methods and materials

Between 1/1998 and 10/2006, 21 patients with T0 or T1 in-breast recurrence of carcinoma were offered interstitial low-dose rate brachytherapy after tumor re-excision as an alternative to salvage mastectomy. All patients had failed lumpectomy followed by standard postoperative external beam radiotherapy (range, 5000–6040cGy) as treatment for the initial breast carcinoma. Seven recurred as ductal carcinoma in situ, 2 as infiltrating lobular carcinoma, and 12 as recurrent invasive carcinoma. The recurrent tumors were excised with final margins of resection free of residual disease per National Surgical Adjuvant Breast and Bowel Project definition. Tumor bed implantation was then carried out with an interstitial technique using 192Ir with the target volume consisting of the tumor bed plus a minimum 1.0-cm clinical margin. The required minimum dose delivered to the target volume was 4500–5000cGy (range, 4500–5530).

Results

Twenty of 21 patients were free of local disease with a median observation time of 40 months (range, 3–69). The single patient who developed a second local recurrence was treated successfully with simple mastectomy. Two patients succumbed to systemic disease at 17 and 24 months after salvage implant therapy. One patient developed a contralateral breast cancer. Cosmetic results defined by the National Surgical Adjuvant Breast and Bowel Project cosmesis scale were acceptable. One patient developed a localized seroma requiring multiple needle aspirations before complete resolution. Two patients developed localized skin breakdown in the tumor bed. One healed after 6 months of conservative treatment. The other healed 9 months later with Grade II cosmesis. This patient also developed a concurrent postoperative wound infection.

Conclusions

Repeat lumpectomy followed by brachytherapy is feasible and may be an acceptable alternative to salvage mastectomy in patients who locally fail conservation breast therapy; however, longer followup and greater patient numbers may be needed to better define the role of salvage brachytherapy.

Keywords: Breast cancer, Interstitial brachytherapy, Retreatment, Cosmesis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1538-4721(07)00278-4

doi:10.1016/j.brachy.2007.12.001

Brachytherapy
Volume 7, Issue 1 , Pages 29-36, January 2008